The Safety of Paclitaxel-Coated Devices for Patients with Peripheral Artery Disease
Sign Up to like & getrecommendations! Published in 2021 at "Current Cardiology Reports"
DOI: 10.1007/s11886-021-01477-4
Abstract: Peripheral artery disease (PAD) is a common, debilitating disease that impacts 8.5 million Americans and carries a poor prognosis. The most common manifestation of lower extremity PAD is claudication—a condition which significantly reduces quality of… read more here.
Keywords: coated devices; safety; mortality; paclitaxel coated ... See more keywords
Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0275888
Abstract: Background Clinical benefit of paclitaxel-coated devices for patients with peripheral arterial disease has been confirmed in randomized controlled trials (RCTs). A meta-analysis published in 2018 identified late mortality risk over a long follow-up period due… read more here.
Keywords: safety paclitaxel; mortality; coated devices; paclitaxel coated ... See more keywords
Repetition of Paclitaxel-Coated Devices for the Treatment of Lower Extremity Artery Disease: Mortality Outcomes and Predictors.
Sign Up to like & getrecommendations! Published in 2023 at "Acta Cardiologica Sinica"
DOI: 10.6515/acs.202303_39(2).20220815b
Abstract: Background A recent meta-analysis reported late excess mortality in patients treated with paclitaxel-coated devices (PCDs) for symptomatic femoropopliteal disease. However, this finding is controversial. Objectives To investigate the impact on mortality and predictors of repeat… read more here.
Keywords: lower extremity; disease; mortality; coated devices ... See more keywords